Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Feb;56(2):203-9.
doi: 10.1136/gut.2006.100594. Epub 2006 Sep 27.

Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum

Affiliations

Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum

Mar Guilarte et al. Gut. 2007 Feb.

Abstract

Background: Increased numbers of mast cells and mast cell activation in distal gut segments are associated with symptom onset and severity in irritable bowel syndrome (IBS). Although upper gut symptoms are common, mast cells have not been thoroughly evaluated in proximal gut in IBS patients.

Methods: Jejunal biopsies obtained by Watson's capsule, aspiration of intestinal fluid and one blood sample were obtained in 20 diarrhoea-predominant patients with IBS (D-IBS) and 14 healthy volunteers (H). Psychological stress (Holmes-Rahe Scale) and depression (Beck's Depression Inventory) were evaluated at baseline and food and respiratory allergy excluded. Biopsies were processed for H&E staining and microscopic inflammation assessed by counting intraepithelial lymphocytes. Mast cells in lamina propria were counted by immunohistochemistry with CD117 (c-kit). Tryptase concentration was measured in intestinal fluid and serum.

Results: D-IBS patients showed higher psychological stress than healthy volunteers (D-IBS: 203 (SD 114) v H: 112 (SD 99); p = 0.019). Immunohistochemical staining of jejunal mucosa revealed mild increase in intraepithelial CD3+ cells in D-IBS patients (D-IBS: 15.3 (SD 5.5; 95% CI 12.7 to 17.9) v H: 10.3 (SD 3.9; 95% CI 8.0 to 12.5); p = 0.006). Moreover, D-IBS patients showed marked increase in mast cells numbers (D-IBS: 34 (SD 9.3); H: 15.3 (SD 4.4) mast cells/hpf; p<0.001) and higher tryptase concentration in jejunal fluid (D-IBS: 0.45 (SD 0.38); H: 0.09 (SD 0.10) microg/l; p = 0.005). Upper gut symptoms were not associated with gender, mast cell counts, jejunal tryptase or basal stress.

Conclusion: This jejunal mucosal inflammatory profile may help identify diarrhoea-predominant IBS, a stress-related disorder.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

Similar articles

Cited by

References

    1. Horwitz B J, Fisher R S. The irritable bowel syndrome. N Engl J Med 20013441846–1850. - PubMed
    1. Bercik P, Verdu E F, Collins S M. Is irritable bowel syndrome a low‐grade inflammatory bowel disease? Gastroenterol Clin N Am 200534235–245. - PubMed
    1. Talley N J, Spiller R. Irritable bowel syndrome: a little understood organic bowel disease? Lancet 2002360555–564. - PubMed
    1. Palsson O S, Drossman D A. Psychiatric and psychological dysfunction in irritable bowel syndrome and the role of psychological treatments. Gastroenterol Clin N Am 200534281–303. - PubMed
    1. Mönnikes H, Tebbe J J, Hildebrandt M.et al Role of stress in functional gastrointestinal disorders. Evidence for stress‐induced alterations in gastrointestinal motility and sensitivity. Dig Dis 200119201–211. - PubMed

Publication types

MeSH terms